GEHC

CHICAGO, September 22, 2026--The Board of Directors of GE HealthCare Technologies Inc. (Nasdaq: GEHC) today declared a cash dividend of $0.04 per share of Common Stock for the third quarter of 2026, an increase of 14% from the previous quarter. The dividend will be payable on November 13, 2026, to all shareholders of record as of October 23, 2026.

CHICAGO, September 22, 2026--GE HealthCare (Nasdaq: GEHC) today announced the appointment of Pascal Desroches, Senior Executive Vice President and Chief Financial Officer (CFO) of AT&T (NYSE: T), a Fortune 50 company, to its Board of Directors, effective January 4, 2027. Mr.

Needham has started coverage on GE Healthcare Technologies, giving it a Buy rating and a $93 price target. The firm sees a potential 44% upside after the company slid nearly 21% year‑to‑date.

The Board of Directors of GE HealthCare Technologies Inc. (NASDAQ:GEHC) today declared a cash dividend of $0.04 per share of Common Stock for the third quarter of 2026, an increase of 14% from the previous quarter. The

Analysts have begun coverage on several stocks, including a Buy rating for GEHC at $93. The list also includes RSI, SNDK, WPC, and a Hold on Nike.

Needham’s David Saxon has initiated coverage on GE HealthCare Technologies with a Buy rating. He set a price target of $93 for the stock.

GE HealthCare Technologies launched CareIntellect, an AI SaaS tool that predicts hospital capacity issues up to 72 hours ahead. Despite the new software, the stock has seen a 13.38% drop over 30 days and a 21.75% decline year‑to‑date.